Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
Clinical trial NCT03810339 · RECRUITING
Trial details
- NCT number
- NCT03810339
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2028-01-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.